Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
142M
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
2.17M
-
Shares change
-
+2.17M
-
Total reported value, excl. options
-
$17.9M
-
Value change
-
+$17.9M
-
Number of buys
-
12
-
Price
-
$8.24
Significant Holders of Applied Therapeutics, Inc. - COMMON STOCK (APLT) as of Q2 2019
12 filings reported holding APLT - Applied Therapeutics, Inc. - COMMON STOCK as of Q2 2019.
Applied Therapeutics, Inc. - COMMON STOCK (APLT) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2.17M shares
of 142M outstanding shares and own 1.53% of the company stock.
Largest 10 shareholders include FMR LLC (586K shares), Knoll Capital Management, LP (467K shares), EMERALD MUTUAL FUND ADVISERS TRUST (461K shares), ALKEON CAPITAL MANAGEMENT LLC (400K shares), Sofinnova Investments, Inc. (142K shares), MILLENNIUM MANAGEMENT LLC (56.2K shares), GOLDMAN SACHS GROUP INC (24.7K shares), Bank of New York Mellon Corp (20.8K shares), NORTHERN TRUST CORP (7.14K shares), and UBS Group AG (2.14K shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.